Qaytona is free while it's in beta — Get started

Ingredients

Lumbrokinase

Earthworm Fibrinolytic Enzyme · Lumbricus rubellus enzyme · Earthworm Powder Enzyme

Snapshot

IndicationsContraindications
  • Cerebral infarction1
  • Stable angina2
  • Pulmonary thromboembolism3

    Lumbrokinase is a complex of serine protease enzymes extracted from earthworms (Pheretima) with specific fibrinolytic activity, used clinically in China for cardiovascular and cerebrovascular thrombotic disease4. Supplementation follows from that effect: cerebral infarction, stable angina, and pulmonary thromboembolism, typically in patients already on standard antithrombotic care.

    Human research is limited to about five small trials, covering cerebral infarction, secondary stroke prevention, stable angina, pulmonary thromboembolism, and tolerability in healthy adults. In cerebral infarction, a 2000 single-blind randomized trial found a greater stroke score improvement than in controls1. A 2016 crossover trial in healthy adults found no significant difference from placebo in hemostasis parameters5. In a 2025 preclinical study, a lumbrokinase-loaded hydrogel promoted bone regeneration in cranial defects; no human trial has tested this. Products are sold as capsules, with 34 products listing lumbrokinase; see Form comparison.

    The caution centers on bleeding: lumbrokinase prolonged clotting time and lowered fibrinogen in the cerebral infarction trial1. The pulmonary thromboembolism study gave it alongside low molecular weight heparin and warfarin, so anticoagulant and antiplatelet co-use is reported rather than excluded.

    Last updated October 15, 2026. Read how we make monographs.

    In the full monograph

    20 sources, 14 studies

    • When to useThe situations practitioners use it for, each with the reason and the study behind it.
    • SafetyWho should avoid it, who needs extra care, and the side effects reported in studies.
    • InteractionsThe medicines and supplements it interacts with, the effect of each, and what labeling says to watch.
    • Protocol notesThe doses used in studies, how and when they were taken, and how the forms on the market compare.
    • How it worksWhat it is and how it works in the body, in plain terms.
    • Published studiesThe studies behind each use, popular claims checked against them, and trials still under way.
    • Word of mouthWhat patients and practitioners report online, kept separate from the clinical evidence.
    • Clinical perspectiveA closing read of where the evidence is solid, where it is thin, and what has not been studied.

    Sources

    1. 1Changes in coagulation and tissue plasminogen activator after the treatment of cerebral infarction with lumbrokinase.pubmed.ncbi.nlm.nih.govJin, Jin, Zhang et al. · Clinical hemorheology and microcirculation · 2000 · Pubmed
    2. 2Improved myocardial perfusion in stable angina pectoris by oral lumbrokinase: a pilot study.pubmed.ncbi.nlm.nih.govKasim, Kiat, Rohman et al. · Journal of alternative and complementary medicine (New York, N.Y.) · 2009 · Pubmed
    3. 3[Effect of lumbrokinase on patients with acute and moderate risk pulmonary thromboembolism].pubmed.ncbi.nlm.nih.govJiang, Zhang, Peng et al. · Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2017 · Pubmed
    4. 4[Analysis and reflection on pharmacological effects and novel formulation technologies of lumbrokinase from Pheretima].pubmed.ncbi.nlm.nih.govLuo, Zhao, Huang et al. · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica · 2026 · Pubmed
    5. 5The Safety and Tolerability of Lumbrokinase DLBS1033 in Healthy Adult Subjects.pubmed.ncbi.nlm.nih.govTjandrawinata, Yunaidi, Susanto · Drug research · 2016 · Pubmed